This is not a financial advice! I see a test of 3, if we break we might seeing a gap fill. Most info on the chart. Trade carefully!
IMUX is trading with high trading volume. there is a divergence in the RSI indicator.
OK traders, this is not trading advice. I am attempting to turn 5K (approx) into 10k over the rest of the year for a bit of fun and hopefully a bit of profit!! This is trade number 3 today, IMUX is a stock I am quite familiar with, I've lost lots of money with this stock ha ha! IMUX has a trading range between 8 and 13... what I would call a heavily manipulated...
Not much I can say about Immunic that you probably don't already know if you're looking at this, they have dropped nicely lately, this is the bottom it looks like and this ompany has a very impressive pipeline, been waiting a long time to get back into this and I consider this a sale price. At worst you'll make an easy 10 % but with so many catalysts on the way...
IMUX has been trading in the channel for over 6 months. Now it seems it is trying to break it. If it stands the support at 20.20 (used to be resistance), it may look like a good BUY signal. Alternatively, can try to wait if it drops back to the support at 15.00. I think I will give it a try now.
This price move could be a signal that IMUX may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options. Tickeron's A.I.dvisor backtested 41 similar cases where IMUX's price broke its higher Bollinger Band, and 37 of them led to a successful outcome. Odds of Success: 90%....
This is a signal that IMUX's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options. Tickeron's A.I.dvisor identified 68 similar cases where IMUX's stochastic oscillator exited the oversold zone, and 59 of them led to successful outcomes. Odds of Success: 87%. Current price $17.27 crossed the support line at $17.15...
IMUX has without doubt one of the most impressive pipelines I have seen in biotech, the potential here is just massive. I bought stock and I am not selling, this will be good news after good news after more good news. I listened to hour long call with CEO and some of the highlights are as follows: IMU-838 - They have an excellent MS treatment in trials producing...
Immunic, Inc. Reports Positive Top-line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis Study Meets Primary and Key Secondary Endpoints with High Statistical Significance Statistically Significant Reduction of 62% and 70% Data Supports Previously Observed Favorable Safety Profile of IMU-838 in...
great stock, it is up for a gap today but i do believe it will come back down to 17.50-15.49 which i think would be a great opportunity to buy knowing their current progress. they have announce their first patient for Covid 19 and are sponsored for it. I think the stock has potential to reach $21 with the current rate.
Long and short position setup based on trend line analysis and candle stick confirmations.
Major breakout potential Golden cross complete Company Profile Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The...
Targeting $15 next week. Announcement of COVID 19 treatment trials in place. Stop loss at $9.00.
shares are trading higher after the company reported its IMU-838 demonstrated preclinical activity against the coronavirus SARS-CoV-2 it is exploring plans for a Phase 2 clinical trial in coronavirus patients. Source seekignalpha